Skip to main content
. 2021 Jul 30;93:111441. doi: 10.1016/j.nut.2021.111441

Table 1.

Prevalence of mild and severe vitamin D deficiency and COVID-19 data in 20 European countries

Country Reference Sample size (F/M) Age range (y) Mean ± SD vitamin D (nmol/L) COVID-19 infections per million people* COVID-19 deaths per million people* COVID-19 recoveries per million people* % Prevalence of vitamin D deficiency (<50 nmol/L) % Prevalence of severe vitamin D deficiency (<30 nmol/L)
Austria [25] 541 (334/237) 18–80 No info 71 742 1180 50 490.1 48.0 14.4
Belgium [26] 905 (464/441) 20–69 55.4 ± 22.7 92763 2160 87 344 44.8 6.4
Bosnia and Herzegovina [27] 1830 (no info) >18 No info 62 831 2959 55 518.7 66.4 28.5
Bulgaria [28] 2016 (1068/948) 20–80 38.75 ± 17.18 61 073 2611 57 135.6 75.8 21.3
Croatia [29] 791 (660/131) 45.5 54.4 88 042 2007 85 922.3 46.1 21
Finland [30] 798 (no info) 30–64 64.0 ± 28.8 17 028 176 8289.6 6.9 0.9
France [31] 892 (429/463) 18–89 60.0 ± 20 89 748 1694 85 361.3 34.6 9.9
Germany [32] 6995 (3635/3360) 18–79 45.6 44 396 1084 42 965.1 61.5 30.2
Greece [33] 1084 (674/410) ≥18 41.8 ± 25.5 40 386 1212 38 689.8 64.8 28.8
Ireland [34] 1118 (no info) 18–84 No info 53 992 998 50 912.7 43.7 11.4
Italy [35] 74 235 (55 424/18 811) 18–104 68.5 ± 39 70 464 2109 67 224.7 33.3 14.5
Norway [36] 4465 (2424/2041) 40–69 64 ± 19.2 23 756 145 16 284.2 24.7 1.9
Portugal [37] 3092 (1995/1097) ≥18 42.2 ± 17.1 85 253 1679 80 909.7 66.6 21.2
Romania [38] 14 052 (12 347/1705) >21 49.5 ± 25 56 525 1699 54 692.3 52.0 13.2
Russia [39] 1011 (824/187) 18–75 54.8 ± 22.3 36 772 897 33 577.1 47.9 No info
Slovenia [40] 280 (152/128) 18–74 49 ± 26.8 123 636 2124 120 835.4 61.0 21.4
Spain [44] 12 912 (no info) 30–105 30.25 ± 11.35 80 575 1726 76 319.8 64.6 No info
Switzerland [41] 1291 (no info) >60 No info 1248 1248 77 613.3 39.2 8
United Kingdom [42] 6004 (3291/2713) >50 48.7 68 178 1876 63 114.2 55.3 23.7
Ukraine [43] 1639 (no info) 18–82 56.7 ± 21.6 51 294 1197 49 538.4 41.9 4.8

Data up to June 23, 2021.

<25 nmol/L.

Mean age of participants.